In this meta-analysis of randomized controlled trials, the addition of Panax notoginseng to standard treatments improved lung function among participants with chronic obstructive pulmonary disease and blood hypercoagulability. However, the certainty of evidence was low.
This Study Summary was published on March 6, 2024.
